Illuminare Biotechnologies Is A Clinical Stage Biotechnology Company Focused On Intra Operative Nerve Visualization To Reduce The Risk Of Nerve Damageour Proprietary Lead Candidateilluminare 1Is A Small Molecule With An Immediate Onset Of Action And Sustained Duration Of Nerve Illuminationilluminare 1 Just Finished Completing A First In Human Trial In Radical Prostatectomy At Memorial Sloan Kettering Cancer Center To Demonstrate Safety And Initial Efficacy Improving Visualization Of Nervesmore Information About Clinical Trial The Company Expects To Enter Phase 2 In 2025
No conferences found for this company.
| Company Name | Illuminare Biotechnologies |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
